D. Gerding

发表

Survival of influenza viruses on environmental surfaces.

B. Bean, B. M. Moore, B. Sterner, 1982, The Journal of infectious diseases.

Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals

S. Saint, D. Classen, R. Weinstein, 2008, Infection Control & Hospital Epidemiology.

An epidemic, toxin gene-variant strain of Clostridium difficile.

Stuart Johnson, D. Gerding, L. McDonald, 2005, The New England journal of medicine.

Burden of Clostridium difficile Infection in the United States

Lisa G Winston, Yi Mu, J. Meek, 2015 .

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

J. Burke, R. Weinstein, D. Gerding, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

J. Burke, R. Weinstein, D. Gerding, 2007 .

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

S. Berenholtz, D. Classen, R. Weinstein, 2014, Infection Control & Hospital Epidemiology.

Clostridium Difficile-Associated Diarrhea and Colitis

L. Peterson, D. Gerding, Stuart Johnson, 1995, Infection Control & Hospital Epidemiology.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

D. Gerding, J. Pépin, L. McDonald, 2010, Infection Control & Hospital Epidemiology.

A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection

M. Samore, D. Gerding, R. Borotkanics, 2013, PloS one.

An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model

M. Samore, D. Gerding, R. Nelson, 2016, PloS one.

Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphis

C. Woods, P. Savelkoul, E. Kuijper, 2007, Journal of Clinical Microbiology.

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

D. Gerding, J. Edwards, W. Bamberg, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

D. Gerding, W. Bamberg, Z. Beldavs, 2013, JAMA internal medicine.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

D. Gerding, Z. Beldavs, G. Dumyati, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combating antimicrobial resistance: policy recommendations to save lives.

Brad Spellberg, Barry I Eisenstein, Edward Septimus, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime.

L. Peterson, D. Gerding, D. Bamberger, 1987, Clinical therapeutics.

Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy.

D. Gerding, D. Bamberger, G. Daus, 1987, The American journal of medicine.

Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.

L. Peterson, D. Gerding, C. Fasching, 1989, The American journal of medicine.

Use of an anaerobic collection and transport swab device to recover anaerobic bacteria from infected foot ulcers in diabetics.

L. Peterson, D. Gerding, Stuart Johnson, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Foot infections in diabetic patients: the role of anaerobes.

D. Gerding, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

D. Gerding, J. Mcgowan, F. Tenover, 1997, Infection control and hospital epidemiology.

Cleaning and disinfection of fiberoptic endoscopes: evaluation of glutaraldehyde exposure time and forced-air drying.

L. Peterson, D. Gerding, J. Vennes, 1982, Gastroenterology.

Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope.

D. Gerding, J. Vennes, J. Allen, 1987, Gastroenterology.

Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains.

D. Gerding, M. Wilcox, Stuart Johnson, 2018, Anaerobe.

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy

D. Gerding, M. Wagener, C. Bryan, 1992, Antimicrobial Agents and Chemotherapy.

Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole

L. Peterson, D. Gerding, Stuart Johnson, 1992, Annals of Internal Medicine.

Metronidazole resistance in Clostridium difficile.

D. Gerding, S. Johnson, J. L. Sanchez, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Colonization for the Prevention of Clostridium difficile Disease in Hamsters

D. Gerding, S. Sambol, Stuart Johnson, 2002 .

Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.

D. Gerding, S. Burns, C. Evans, 2014, American Journal of Infection Control.

Improved recovery of microorganisms from patients receiving antibiotics with the antimicrobial removal device.

L. Peterson, D. Gerding, C. Shanholtzer, 1983, American journal of clinical pathology.

Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals

S. Saint, D. Classen, R. Weinstein, 2008, Infection Control & Hospital Epidemiology.

Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects

L. Peterson, D. Gerding, J. Eckfeldt, 1982, Antimicrobial Agents and Chemotherapy.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Antonio Ramos, T. V. Van Schooneveld, D. Gerding, 2015, JAMA.

Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside

D. Gerding, S. Sambol, Stuart Johnson, 2018, Front. Microbiol..

The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection

D. Gerding, Stuart Johnson, 2017, Mayo Clinic proceedings. Innovations, quality & outcomes.

Editorial Commentary: Whole-Genome Sequencing of Clostridium difficile: Exquisitely Sensitive but Not Yet Optimally Applied.

D. Gerding, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Colonization for the prevention of Clostridium difficile disease in hamsters.

D. Gerding, S. Sambol, Stuart Johnson, 1999, The Journal of infectious diseases.

Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.

D. Gerding, S. Sambol, Stuart Johnson, 2003, The Journal of infectious diseases.

Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines.

D. Gerding, 2012, Discovery medicine.

Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects

D. Gerding, M. Seiberling, S. Villano, 2012, Antimicrobial Agents and Chemotherapy.

Nosocomial febrile illnesses in patients on an internal medicine service.

D. Gerding, G. Filice, R. Hughes, 1989, Archives of internal medicine.

Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.

D. Gerding, T. Larson, 1985, The American journal of medicine.

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.

E. Cheek, D. Gerding, S. Sambol, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure.

Y. Carmeli, M. Samore, D. Gerding, 2006, Microbial drug resistance.

Predominance of a Single Restriction Endonuclease Analysis Group with Intrahospital Subgroup Diversity Among Clostridium difficile Isolates at Two Chicago Hospitals

D. Gerding, S. Sambol, Stuart Johnson, 2002, Infection Control & Hospital Epidemiology.

Difference in the Incidence of Clostridium difficile Among Patients Infected With Human Immunodeficiency Virus Admitted to a Public Hospital and a Private Hospital

R. Weinstein, D. Gerding, F. Kocka, 2002, Infection Control & Hospital Epidemiology.

Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals.

M. Samore, D. Gerding, F. Tenover, 1997, The Journal of infectious diseases.

DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak

D. Anderson, D. Gerding, M. Vasil, 1991, Journal of clinical microbiology.

U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016

D. Snydman, B. A. Forbes, D. Gerding, 2019, Antimicrobial Agents and Chemotherapy.

Complete Genome Sequence of Clostridioides difficile Epidemic Strain DH/NAP11/106/ST-42, Isolated from Stool from a Pediatric Patient with Diarrhea

D. Gerding, D. Hecht, A. Hauser, 2017, Genome Announcements.

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.

F. Weaver, D. Gerding, Stuart Johnson, 2007, The Journal of infection.

Fecal incontinence in hospitalized patients who are acutely ill.

D. Gerding, D. Bliss, S. Johnson, 2000, Nursing research.

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection

K. Garey, D. Gerding, E. Dubberke, 2020, Open forum infectious diseases.

Efficacy of bezlotoxumab in trial participants infected with Clostridioides difficile strain BI associated with poor outcomes.

D. Gerding, E. Goldstein, M. Wilcox, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Workshop on Immunizations in Older Adults: Identifying Future Research Agendas

J. Halter, K. Schmader, R. Fuldner, 2010, Journal of the American Geriatrics Society.

SHEA Conference on Antimicrobial Resistance

W. Martone, D. Gerding, 2000, Infection Control & Hospital Epidemiology.

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

D. Gerding, S. Sambol, Stuart Johnson, 2009, Anaerobe.

Cephalothin clearance of Staphylococcus aureus from two experimental infection sites in the presence and absence of local phagocytic cells.

B. Bean, L. Peterson, D. Gerding, 1987, The Journal of antimicrobial chemotherapy.

Incidence of infection in systemic lupus erythematosus.

R. S. Gordon, D. Gerding, J. Decker, 1974, Arthritis and rheumatism.

Cephalosporin and Aminoglycoside Concentrations in Peritoneal Capsular Fluid in Rabbits

D. Gerding, W. H. Hall, E. A. Schierl, 1976, Antimicrobial Agents and Chemotherapy.

Neutrophil localization in acute and chronic experimental abscesses.

D. Gerding, D. Bamberger, K. Bettin, 1987, The Journal of laboratory and clinical medicine.

Differential Immunodetection of Toxin B from Highly Virulent Clostridium difficile BI/NAP-1/027

D. Duffy, D. Gerding, Linan Song, 2015, Journal of Clinical Microbiology.

Global Epidemiology of Clostridium difficile Infection in 2010

D. Gerding, 2010, Infection Control & Hospital Epidemiology.

Screening and treatment of infections caused by resistant enterococci

D. Gerding, D. .. Herman, D. J. Herman, 1991, Antimicrobial Agents and Chemotherapy.

Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantiﬁcation of Clostridium difﬁcile Toxins in Stool

D. Duffy, D. Gerding, Linan Song, 2015 .

Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases.

L. Peterson, D. Gerding, Stuart Johnson, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015

Corinne M. Davis, D. Gerding, Z. Beldavs, 2019, Journal of General Internal Medicine.

Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient.

L. Peterson, D. Gerding, L. Van Etta, 1983, Archives of dermatology.

Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients.

D. Gerding, D. Bliss, S. Johnson, 1997, Diagnostic microbiology and infectious disease.

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

D. Gerding, Stuart Johnson, V. Viswanathan, 2010, Journal of bacteriology.

Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.

D. Gerding, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay

L. Peterson, D. Gerding, K. O’Leary, 2001, Annals of Internal Medicine.

1 Comparative genome analysis and global phylogeny of the toxin variant 1 Clostridium difficile PCR Ribotype 017 reveals the evolution of two independent 2 sub-lineages. 3

E. Kuijper, D. Gerding, P. Tsai, 2016 .

In vitro activity of efrotomycin, ciprofloxacin, and six other antimicrobials against Clostridium difficile.

L. Peterson, D. Gerding, C. Clabots, 1987, Diagnostic microbiology and infectious disease.

Reinforcement of an infection control bundle targeting prevention practices for Clostridioides difficile in Veterans Health Administration nursing homes.

C. Woods, C. Donskey, M. Samore, 2019, American journal of infection control.

The search for good antimicrobial stewardship.

D. Gerding, 2001, The Joint Commission journal on quality improvement.

gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee.

L. Peterson, D. Gerding, F. Tenover, 1991, The Journal of infectious diseases.

Toxin Gene Analysis of a Variant Strain ofClostridium difficile That Causes Human Clinical Disease

D. Gerding, S. Sambol, Stuart Johnson, 2000, Infection and Immunity.

Plasmid macroevolution in a nosocomial environment: Demonstration of a persistent molecular polymorphism and construction of a cladistic phylogeny on the basis of restriction data

D. Gerding, Stephen C. Lee, P. Cleary, 2004, Molecular and General Genetics MGG.

Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids

D. Gerding, P. Cleary, S. C. Lee, 1986, Antimicrobial Agents and Chemotherapy.

Nosocomial Multiply Resistant Klebsiella pneumoniae: Epidemiology of an Outbreak of Apparent Index Case Origin

D. Gerding, A. Buxton, W. Stamm, 1979, Antimicrobial Agents and Chemotherapy.

Physical Characterization of Ten R Plasmids Obtained from an Outbreak of Nosocomial Klebsiella pneumoniae Infections

B. C. Peterson, D. Gerding, P. Cleary, 1979, Antimicrobial Agents and Chemotherapy.

Clostridium difficile 30 years on: what has, or has not, changed and why?

D. Gerding, 2009, International journal of antimicrobial agents.

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection

T. Louie, D. Gerding, M. Wilcox, 2015, The Journal of antimicrobial chemotherapy.

Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease

D. Gerding, Stuart Johnson, E. Janoff, 1995, Infection and immunity.

Etiologic diagnosis of acute pneumonia in adults: a growing challenge.

D. Gerding, 1981, Postgraduate medicine.

Penetration of tobramycin into infected extravascular fluids and its therapeutic effectiveness.

D. Gerding, W. H. Hall, E. A. Schierl, 1977, The Journal of infectious diseases.

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

D. Gerding, M. Rupnik, S. Sambol, 2006, The Journal of infectious diseases.

Protein-losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization: a prospective, case-control study.

D. Gerding, Stuart Johnson, S. Johnson, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridium difficile Outbreak Strain BI Is Highly Endemic in Chicago Area Hospitals

Roderick C. Jones, S. Weber, D. Gerding, 2011, Infection Control & Hospital Epidemiology.

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

C. Donskey, D. Gerding, D. Yokoe, 2014, Infection Control & Hospital Epidemiology.

Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates.

D. Gerding, Stuart Johnson, Anilrudh A. Venugopal, 2011, American journal of infection control.

Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope.

D. Gerding, J. Vennes, John I. Allen, 1987, Gastroenterology.

Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.

D. Snydman, B. A. Forbes, D. Gerding, 2020, Anaerobe.

Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

D. Gerding, Z. Beldavs, G. Dumyati, 2020, The New England journal of medicine.

Incidence and Outcome of Clostridium difficile Infection-Beware of Strain Type and Diagnostic Tests.

D. Gerding, 2020, JAMA network open.

Diagnosis and Treatment of Clostridium difficile Infection (CDI)

D. Gerding, L. McDonald, T. File, 2018 .

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study

D. Gerding, W. Bamberg, Z. Beldavs, 2015, Open forum infectious diseases.

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases

Dustin L. Stwalley, D. Gerding, M. Olsen, 2016, BMC Infectious Diseases.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

D. Snydman, B. A. Forbes, D. Gerding, 2015, Antimicrobial Agents and Chemotherapy.

Clostridium difficile Infection Among Veterans Health Administration Patients

J. Neily, P. Mills, D. Gerding, 2015, Infection Control & Hospital Epidemiology.

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

Philip Carling, Ruth Carrico, Curtis J Donskey, 2014, Infection Control & Hospital Epidemiology.

Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.

D. Gerding, E. Goldstein, S. Sambol, 2018, Anaerobe.

Restriction Endonuclease Analysis Typing of Clostridium difficile Isolates.

D. Gerding, S. Sambol, Stuart Johnson, 2016, Methods in molecular biology.

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027

D. Gerding, Stuart Johnson, D. Hecht, 2015, Antimicrobial Agents and Chemotherapy.

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection

T. Louie, D. Gerding, M. Wilcox, 2015, Antimicrobial Agents and Chemotherapy.

Molecular Epidemiology of Clostridium difficile Infections in Children: A Retrospective Cohort Study

D. Gerding, S. Shulman, Sameer J. Patel, 2015, Infection Control & Hospital Epidemiology.

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection

T. Louie, D. Gerding, G. Talbot, 2015 .

International typing study of Clostridium difficile.

D. Gerding, Stuart Johnson, T. Riley, 2014, Anaerobe.

Nontoxigenic Clostridium difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic BI/NAP1/027 C. difficile

D. Gerding, S. Sambol, Stuart Johnson, 2013, Antimicrobial Agents and Chemotherapy.

Does infection with specific Clostridium difficile strains or clades influence clinical outcome?

D. Gerding, Stuart Johnson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic Malignancy

D. Gerding, C. Evans, Stuart Johnson, 2013, Infection Control & Hospital Epidemiology.

Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.

D. Gerding, S. Sambol, Stuart Johnson, 2011, Anaerobe.

Comparison of Strain Typing Results for Clostridium difficile Isolates from North America

A. Wortman, D. Gerding, T. Åkerlund, 2011, Journal of Clinical Microbiology.

Fourteen-Genome Comparison Identiﬁes DNA Markers for Severe-Disease-Associated Strains of Clostridium difﬁcile (cid:1) †

E. Mardis, Mark A. Miller, K. Dewar, 2011 .

Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.

D. Gerding, K. Walker-Bone, M. Llewelyn, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Hypervirulent Clostridium difﬁcile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production (cid:1)

D. Gerding, Stuart Johnson, M. Mallozzi, 2010 .

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.

D. Gerding, E. Goldstein, S. Sambol, 2009, Anaerobe.

Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.

D. Gerding, R. Guerrant, R. Carman, 2009, The Journal of hospital infection.

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.

D. Gerding, S. Sambol, Stuart Johnson, 2009, International journal of antimicrobial agents.

Antimotility agents for the treatment of Clostridium difficile infection: is the juice worth the squeeze?

D. Gerding, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection of hamsters with historical and epidemic BI types of Clostridium difficile.

D. Gerding, S. Sambol, Stuart Johnson, 2007, The Journal of infectious diseases.

New Definitions Will Help, but Cultures are Critical for Resolving Unanswered Questions About Clostridium difficile

D. Gerding, 2007, Infection Control & Hospital Epidemiology.

Treatment of Clostridium difﬁcile Infection

D. Gerding, R. Owens, C. Muto, 2007 .

Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent Strains

A. Witney, D. Gerding, J. Hinds, 2006, Journal of bacteriology.

The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile

L. Peterson, D. Gerding, K. O’Leary, 2020, Journal of clinical medicine.

Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions

D. Gerding, S. Shulman, Sameer J. Patel, 2015, The Pediatric infectious disease journal.

Is pediatric Clostridium difficile infection associated with prior antibiotic exposure?

D. Gerding, L. Kociolek, 2014, Future microbiology.

Revised nomenclature of Clostridium difficile toxins and associated genes.

N. Fairweather, D. Gerding, B. Wren, 2005, Journal of medical microbiology.

Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection.

D. Gerding, S. Shulman, Sameer J. Patel, 2015, Journal of the Pediatric Infectious Diseases Society.

In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics

L. Peterson, D. Gerding, J. Moody, 1984, Antimicrobial Agents and Chemotherapy.

Does antibiotic restriction prevent resistance?

D. Gerding, J. Mcgowan, 1996, New horizons.

Characterization of a nosocomial Clostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing.

L. Peterson, D. Gerding, C. Clabots, 1988, The Journal of infectious diseases.

More than one DNA sequence encodes the 2''-O-adenylyltransferase phenotype

D. Gerding, P. Cleary, S. Lee, 1987, Antimicrobial Agents and Chemotherapy.

Toxin B is essential for virulence of Clostridium difficile

Julian I. Rood, Stuart Johnson, Glen P. Carter, 2009, Nature.

Toxin A-predominant Pathogenic C. difficile: A Novel Clinical Phenotype.

D. Duffy, K. Garey, D. Gerding, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Deﬁning the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difﬁcile Infections

S. Clare, G. Dougan, D. Gerding, 2015 .

Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.

D. Gerding, S. Sambol, Stuart Johnson, 2012, The Journal of infectious diseases.

Clostridium difficile infection in 2010: Advances in pathogenesis, diagnosis and management of CDI

D. Gerding, Stuart Johnson, 2011, Nature Reviews Gastroenterology &Hepatology.

Infection of hamsters with epidemiologically important strains of Clostridium difficile.

D. Gerding, S. Sambol, Stuart Johnson, 2001, The Journal of infectious diseases.

Chapter 8 – Enterotoxemic Infections

D. Gerding, Stuart Johnson, 1997 .

Medical technologists using molecular epidemiology as part of the infection control team.

L. Peterson, D. Gerding, C. Fasching, 1993, Diagnostic microbiology and infectious disease.

Shea Position Paper CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA AND COLITIS

L. Peterson, D. Gerding, Stuart Johnson, 1999 .

Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.

L. Peterson, D. Gerding, S. Johnson, 1990, Archives of internal medicine.

Antimicrobial resistance among enterococci

D. Gerding, D. .. Herman, D. J. Herman, 1991, Antimicrobial Agents and Chemotherapy.

Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatients.

R. Weinstein, D. Gerding, F. Kocka, 2002, Diagnostic microbiology and infectious disease.

Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in Clostridioides difficile detection and a trend toward increased strain diversity

D. Gerding, Stuart Johnson, S. Pacheco, 2020, Infection Control & Hospital Epidemiology.

Protection from Clostridium difﬁcile Infection in CD4 T Cell- and Polymeric Immunoglobulin Receptor-Deﬁcient Mice

D. Gerding, Pehga F. Johnston, Katherine L. Knighta, 2014 .

Protection from Clostridium difficile Infection in CD4 T Cell- and Polymeric Immunoglobulin Receptor-Deficient Mice

D. Gerding, K. Knight, Pehga F. Johnston, 2013, Infection and Immunity.

Frequency of Binary Toxin Genes among Clostridium difficile Strains That Do Not Produce Large Clostridial Toxins

D. Gerding, M. Rupnik, Stuart Johnson, 2003, Journal of Clinical Microbiology.

International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants

M. Delmée, D. Gerding, S. Sambol, 2003, Journal of Clinical Microbiology.

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

D. Gerding, E. Goldstein, S. Sambol, 2011, Antimicrobial Agents and Chemotherapy.

Metronidazole Susceptibility in Clostridium difficile Isolates Recovered from Cases of C. difficile -associated Disease Treatment Failures and Successes

D. Gerding, Stuart Johnson, M. Olson, 1999 .

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

K. Carroll, K. Garey, J. Bakken, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Guideline Recommendations: Optimal Timing of Publication and Resulting Rate of Adoption.

D. Gerding, Stuart Johnson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of endogenous Clostridium difficile toxin antibodies on recurrence of C. difficile infection

Judong Shen, R. Railkar, D. Gerding, 2020 .

Treatment of Recurrent Clostridium difficile Infection.

D. Gerding, Stuart Johnson, 2019, JAMA.

Cadazolid for the treatment of Clostridium difficile infection: results of two double- blind, double-dummy, non-inferiority, randomised controlled phase 3 trials

D. Gerding, C. Nord, O. Cornely, 2019 .

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

L. Peterson, D. Gerding, Stuart Johnson, 1989, The Journal of infectious diseases.

BASIC—ALIMENTARY TRACT A Mouse Model of Clostridium difficile-Associated Disease

D. Gerding, C. Kelly, Xinhua Chen, 2008 .

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.

D. Gerding, Stuart Johnson, D. Hecht, 2009, Anaerobe.

Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.

D. Gerding, Stuart Johnson, E. Janoff, 1992, The Journal of infectious diseases.

Differential immunodetection of toxin B from highly virulent C. difficile BI/NAP-1/027 1

D. Duffy, D. Gerding, N. Pollock, 2015 .

Increased dosage requirements of gentamicin in burn patients.

D. Gerding, R. Sawchuk, D. Zaske, 1976, The Journal of trauma.

Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis.

D. Gerding, W. H. Hall, E. A. Schierl, 1977, Annals of internal medicine.

Comparative Activities of the Oxa-β-Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative Bacilli

D. Gerding, W. H. Hall, B. J. Opfer, 1980, Antimicrobial Agents and Chemotherapy.

Laboratory detection of Clostridium difficile. A comparison of media and incubation systems.

L. Peterson, D. Gerding, C. Shanholtzer, 1995, American Journal of Clinical Pathology.

Favorable prognosis of patients with prosthetic valve endocarditis caused by gram-negative bacilli of the HACEK group.

D. Gerding, D. Meyer, 1988, The American journal of medicine.

Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration.

D. Gerding, S. Sambol, Stuart Johnson, 2003, Anaerobe.

Epidemic Strains of Clostridium difficile: REA, PFGE, PCR-

C. Woods, P. Savelkoul, D. Gerding, 2007 .

Oral Fluoroquinolone Therapy for Clostridium difficile Enterocolitis-Reply

D. Gerding, 1988 .

Clostridium difficile plasmid isolation as an epidemiologic tool

L. Peterson, D. Gerding, M. Mulligan, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile

L. Peterson, D. Gerding, M. Mulligan, 1988, Journal of clinical microbiology.

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

M. Pirmohamed, G. Dougan, J. Parkhill, 2012, Nature Genetics.

Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital

D. Gerding, D. Hecht, Sameer J. Patel, 2018, The Journal of antimicrobial chemotherapy.

Antigen-induced experimental septic arthritis in rabbits after intraarticular injection of Staphylococcus aureus.

D. Gerding, R. Shafer, M. Mahowald, 1986, The Journal of infectious diseases.

Use of technetium-99m methylene diphosphonate and gallium-67 citrate scans after intraarticular injection of Staphylococcus aureus into knee joints of rabbits with chronic antigen-induced arthritis.

D. Gerding, R. Shafer, M. Mahowald, 1986, The Journal of infectious diseases.

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

L. Peterson, D. Gerding, Stuart Johnson, 1990, The American journal of medicine.

Disease associated with Clostridium difficile infection.

D. Gerding, 1989, Annals of internal medicine.

PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS

D. Gerding, R. Gebhard, M. Olson, 1983, The Lancet.

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Mark H. Wilcox, D. Gerding, M. Wilcox, 2009, Nature Reviews Microbiology.

In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile

L. Peterson, D. Gerding, E. Fasola, 1990, Antimicrobial Agents and Chemotherapy.

Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?

D. Gerding, Dale N. Gerding, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tissue penetration of the new quinolones in humans.

D. Gerding, J. Hitt, 1989, Reviews of infectious diseases.

Evaluation of a Commercial Microdilution System for Quantitative Susceptibility Testing of Aminoglycosides Against Multidrug-Resistant, Gram-Negative Bacilli

L. Peterson, D. Gerding, W. H. Hall, 1980, Antimicrobial Agents and Chemotherapy.

Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.

L. Peterson, D. Gerding, C. Shanholtzer, 1986, American journal of clinical pathology.

Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.

L. Peterson, D. Gerding, J. Moody, 1987, The American journal of medicine.

In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.

L. Peterson, D. Gerding, C. Fasching, 1987, Diagnostic microbiology and infectious disease.

Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.

L. Peterson, D. Gerding, D. Bamberger, 1986, The Journal of antimicrobial chemotherapy.

In vitro activity of ciprofloxacin combined with azlocillin

L. Peterson, D. Gerding, J. Moody, 1985, Antimicrobial Agents and Chemotherapy.

Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model

L. Peterson, D. Gerding, C. Fasching, 1984, Antimicrobial Agents and Chemotherapy.

In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp

L. Peterson, D. Gerding, C. E. Hughes, 1984, Antimicrobial Agents and Chemotherapy.

Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.

L R Peterson, L. Peterson, D. Gerding, 1986, The Journal of antimicrobial chemotherapy.

MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques

L. Peterson, D. Gerding, C. Shanholtzer, 1984, Antimicrobial Agents and Chemotherapy.

Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model.

L. Peterson, D. Gerding, C. Fasching, 1991, Diagnostic microbiology and infectious disease.

Occurrence and reproducibility of the "skip" phenomenon in bactericidal testing of Staphylococcus aureus.

L. Peterson, D. Gerding, C. Shanholtzer, 1987, Diagnostic microbiology and infectious disease.

Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.

L. Peterson, D. Gerding, C. Fasching, 1987, Diagnostic microbiology and infectious disease.

High-Pressure Liquid Chromatographic Analysis for Quantitation of BMY-28142 and Ceftazidime in Human and Rabbit Serum

L. Peterson, D. Gerding, C. Fasching, 1986 .

Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics.

L. Peterson, D. Gerding, W. H. Hall, 1977, The Journal of infectious diseases.

Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs

L. Peterson, D. Gerding, C. E. Hughes, 1984, Antimicrobial Agents and Chemotherapy.

Fungal meningitis manifesting as hydrocephalus.

G. Sarosi, L. Peterson, D. Gerding, 1983, Archives of internal medicine.

GyrA sequence analysis of Staphylococcus aureus and methicillin-resistant S. aureus strains selected, in vitro, for high-level ciprofloxacin resistance.

L. Peterson, D. Gerding, C. Fasching, 1993, Diagnostic microbiology and infectious disease.

Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts.

L. Peterson, D. Gerding, 1980, Reviews of infectious diseases.

Antibiotic Penetrance of Ascitic Fluid in Dogs

D. Gerding, J. Sullivan, W. H. Hall, 1976, Antimicrobial Agents and Chemotherapy.

Screening andTreatment ofInfections Causedby Resistant Enterococci

D. Gerding, D. .. Herman, D. J. Herman, 1991 .

Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms

L. Peterson, D. Gerding, T. Larson, 1985, Journal of clinical microbiology.

Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model.

L. Peterson, D. Gerding, C. Fasching, 1982, The Journal of infectious diseases.

Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.

L. Peterson, D. Gerding, C. Fasching, 1990, The Journal of laboratory and clinical medicine.

Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.

L. Peterson, D. Gerding, C. Fasching, 1985, The Journal of antimicrobial chemotherapy.

Evaluation of Three Newer Methods for Investigating Protein Interactions of Penicillin G

B. M. Moore, L. Peterson, D. Gerding, 1977, Antimicrobial Agents and Chemotherapy.

Effect of method of administration on extravascular penetration of four antibiotics

L. Peterson, D. Gerding, C. Fasching, 1982, Antimicrobial Agents and Chemotherapy.

Assay of netilmicin, using enzyme immunoassay for gentamicin

L. Peterson, D. Gerding, J. Eckfeldt, 1982, Antimicrobial Agents and Chemotherapy.

Prediction of Cefazolin Penetration into High- and Low-Protein-Containing Extravascular Fluid: New Method for Performing Simultaneous Studies

L. Peterson, D. Gerding, 1978, Antimicrobial Agents and Chemotherapy.

Serious staphylococcal infections with strains tolerant to bactericidal antibiotics.

L. Peterson, D. Gerding, W. H. Hall, 1979, Archives of internal medicine.

Determination of tolerance to antibiotic bactericidal activity on Kirby-Bauer susceptibility plates.

L. Peterson, D. Gerding, W. H. Hall, 1980, American journal of clinical pathology.

Medium-Dependent Variation in Bactericidal Activity of Antibiotics Against Susceptible Staphylococcus aureus

L. Peterson, D. Gerding, W. H. Hall, 1978, Antimicrobial Agents and Chemotherapy.

Interaction of cephalosporins with human and canine serum proteins.

L. Peterson, D. Gerding, 1978, The Journal of infectious diseases.

Comparative tissue and extravascular fluid concentrations of ceftizoxime.

L. Peterson, D. Gerding, 1982, The Journal of antimicrobial chemotherapy.

High-pressure liquid chromatographic assay of ceftizoxime with an anion-exchange extraction technique

L. Peterson, D. Gerding, C. Fasching, 1982, Antimicrobial Agents and Chemotherapy.

Assay of 27 antimicrobials using a microbiological method.

L. Peterson, D. Gerding, C. Fasching, 1983, Minnesota medicine.

Breakthroughs in the treatment and prevention of Clostridium difficile infection

D. Gerding, L. Kociolek, 2016, Nature Reviews Gastroenterology &Hepatology.

Corynebacterium equi: a review of 12 cases of human infection.

G. Filice, D. Gerding, L. Van Etta, 1983, Reviews of infectious diseases.

Prediction of the concentration of penicillins in ascitic fluid from serum kinetics and protein binding of the antibiotics in serum and ascitic fluid of dogs.

L. Peterson, D. Gerding, W. H. Hall, 1978, The Journal of infectious diseases.

Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains

M. Samore, D. Gerding, R. Arbeit, 1994, Journal of clinical microbiology.

Comparison Study of the Kinetics of Ceftizoxime Penetration into Extravascular Spaces with Known Surface Area/Volume Ratio In Vitro and In Vivo in Rabbits

L. Peterson, D. Gerding, C. Fasching, 1983, Antimicrobial Agents and Chemotherapy.

Treatment of Pseudomonas endophthalmitis associated with prosthetic intraocular lens implantation.

D. Gerding, W. H. Hall, M. D. Clark, 1979, American journal of ophthalmology.

Ascitic Fluid Cephalosporin Concentrations: Influence of Protein Binding and Serum Pharmacokinetics

L. Peterson, D. Gerding, W. H. Hall, 1978, Antimicrobial Agents and Chemotherapy.

The penetration of antibiotics into peritoneal fluid.

D. Gerding, W. H. Hall, 1975, Bulletin of the New York Academy of Medicine.

Effectiveness of Liquid Soap vs. Chlorhexidine Gluconate for the Removal of Clostridium difficile from Bare Hands and Gloved Hands

D. Gerding, C. Clabots, K Bettin, 1994, Infection Control & Hospital Epidemiology.

Treatment of pulmonary sporotrichosis.

D. Gerding, 1986, Seminars in respiratory infections.

K. Carroll, K. Garey, J. Bakken, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Utility of a Commercial PCR Assay and a Clinical Prediction Rule for Detection of Toxigenic Clostridium difficile in Asymptomatic Carriers

C. Donskey, M. Samore, D. Gerding, 2013, Journal of Clinical Microbiology.

Evaluation of the 24-h API 20A anaerobe system for identification of Clostridium difficile

L. Peterson, D. Gerding, C. Shanholtzer, 1984, Journal of clinical microbiology.

Pasteurella multocida peritonitis in hepatic cirrhosis with ascites.

D. Gerding, W. Hall, M. Khan, 1976, Gastroenterology.

The Impact of Recurrent Clostridium difficile Infection on Patients’ Prevention Behaviors

Michael Y. Lin, W. Trick, F. Weaver, 2017, Infection Control & Hospital Epidemiology.

Clostridium difficile--associated diarrhea.

D. Gerding, Stuart Johnson, S. Johnson, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea

M. Samore, D. Gerding, Stuart Johnson, 1998, The Lancet.

Diagnosis of Clostridium difficile--associated disease: patient selection and test perfection.

D. Gerding, 1996, The American journal of medicine.

Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.

D. Gerding, James T. Lee, M. Olson, 1994 .

Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use

D. Gerding, S. Pear, T. Williamson, 1994, Annals of Internal Medicine.

Optimal methods for identifying Clostridium difficile infections.

D. Gerding, J. Brazier, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

L. Peterson, D. Gerding, Stuart Johnson, 1992, The Journal of infectious diseases.

Nosocomial Clostridium difficile colonisation and disease

L. Peterson, D. Gerding, Stuart Johnson, 1990, The Lancet.

Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole.

L. Peterson, D. Gerding, Stuart Johnson, 1990, American journal of surgery.

Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.

L. Peterson, D. Gerding, M. Schwartz, 1986, Archives of internal medicine.

Relation between in vivo abscess localization and in vitro migration and adherence of neutrophils.

D. Gerding, D. Bamberger, M. Elson, 1985, The Journal of infectious diseases.

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

L. Peterson, D. Gerding, R. Hughes, 1991, Antimicrobial Agents and Chemotherapy.

Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium

M. Quail, G. Dougan, J. Parkhill, 2009, Genome Biology.

Pleural effusion associated with viral hepatitis.

D. Gerding, P. Gross, 1971, Gastroenterology.

PLEURAL EFFUSION ASSOCIATED WITH VffiAL HEPATITIS

D. Gerding, P. Gross, 1971 .

Measures to control and prevent Clostridium difficile infection.

Carlene A. Muto, D. Gerding, R. Owens, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

D. Gerding, T. Larson, 1986, The American journal of medicine.

Clindamycin-Resistant Clostridium difficile

D. Gerding, Stuart Johnson, 2001 .

Ciprofloxacin penetration into extravascular spaces in a rabbit model

L. Peterson, D. Gerding, C. Fasching, 1984, Antimicrobial Agents and Chemotherapy.

Effects of biliary obstruction on hepatic clearance of bacteria.

D. Gerding, R. Barke, J. Vennes, 1989, Archives of surgery.

Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections

D. Gerding, I. Youngster, 2017, The American Journal of Gastroenterology.

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

D. Gerding, E. Dubberke, H. Dupont, 2022, BMC Infectious Diseases.

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

D. Gerding, E. Dubberke, S. Khanna, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A mouse model of Clostridium difficile-associated disease.

Jeffrey D Goldsmith, D. Gerding, C. Kelly, 2008, Gastroenterology.

Efficacy of routine fiberoptic endoscope cleaning and disinfection for killing Clostridium difficile.

L. Peterson, D. Gerding, R. Gebhard, 1986, Gastrointestinal endoscopy.

Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects

B. Bean, L. Peterson, D. Gerding, 1981, Antimicrobial Agents and Chemotherapy.

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

D. Gerding, J. Mcgowan, F. Tenover, 1997, Infection Control & Hospital Epidemiology.

Strategies to Prevent Surgical Site Infections in Acute Care Hospitals

Helen Burstin, Sanjay Saint, Victoria Fraser, 2008, Infection Control & Hospital Epidemiology.

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals

Helen Burstin, Sanjay Saint, Victoria Fraser, 2008, Infection Control & Hospital Epidemiology.

In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004

D. Gerding, S. Sambol, Stuart Johnson, 2007, Antimicrobial Agents and Chemotherapy.

Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.

L. Peterson, D. Gerding, C. Fasching, 1994, Chemotherapy.

Influence of protein binding on therapeutic efficacy of cefoperazone

L. Peterson, D. Gerding, C. Fasching, 1989, Antimicrobial Agents and Chemotherapy.

Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model

L. Peterson, D. Gerding, C. Fasching, 1984, Antimicrobial Agents and Chemotherapy.

Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime

L. Peterson, D. Gerding, L. Van Etta, 1982, Antimicrobial Agents and Chemotherapy.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

Sean M Berenholtz, Robert Wise, Michael Klompas, 2014, Infection Control & Hospital Epidemiology.

The association between Staphylococcus aureus bacteremia and bacteriuria.

D. Gerding, K. Crossley, B. K. Lee, 1978, The American journal of medicine.

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections

S. Clare, G. Dougan, D. Gerding, 2015, mBio.

Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals

S. Saint, D. Classen, R. Weinstein, 2008, Infection Control & Hospital Epidemiology.

Cavitary pneumonia associated with tularemia.

D. Gerding, W. H. Hall, A. J. Kozak, 1978, Chest.

Diagnosis and Treatment of Clostridium difficile Infection

T. File, D. Gerding, L. McDonald, 2016, Infectious diseases in clinical practice.

Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool

D. Duffy, D. Gerding, Linan Song, 2015, Journal of Clinical Microbiology.

Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile

D. Gerding, V. Viswanathan, M. Mallozzi, 2013, PloS one.

Comparative in vitro activity of BMY-28142 alone and in combination with amikacin against clinical strains of Pseudomonas aeruginosa, Staphylococcus aureus and enterobacteriaceae

L. Peterson, D. Gerding, J. Moody, 1986 .

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.

D. Gerding, Stuart Johnson, Jennifer R. O’Connor, 2009, Gastroenterology.

Treatment of Clostridium difficile infection.

Carlene A. Muto, D. Gerding, R. Owens, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Host Immune Responses to Clostridioides difficile: Toxins and Beyond

E. Kuijper, D. Gerding, W. Smits, 2021, Frontiers in Microbiology.

Clostridium difficile binary toxin CDT

D. Gerding, K. Aktories, M. Rupnik, 2013, Gut microbes.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

D. Gerding, G. Rahav, M. Wilcox, 2017, The New England journal of medicine.

Strategies to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus in Acute Care Hospitals

Helen Burstin, Sanjay Saint, Victoria Fraser, 2008, Infection Control & Hospital Epidemiology.

Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis.

L. Peterson, D. Gerding, C. McClain, 1985, The American journal of medicine.

Prospective study of gram-stained stool smears in diagnosis of Clostridium difficile colitis

L. Peterson, D. Gerding, C. Shanholtzer, 1983, Journal of clinical microbiology.

Extravascular penetration of tobramycin and netilmicin in a subcutaneous visking chamber model in rabbits

L. Peterson, D. Gerding, T. Larson, 1983, Antimicrobial Agents and Chemotherapy.

Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.

L. Peterson, D. Gerding, C. Fasching, 1987, The American journal of medicine.

Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile

D. Gerding, S. Sambol, Stuart Johnson, 2008, Antimicrobial Agents and Chemotherapy.

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages

J. Weese, E. Kuijper, D. Gerding, 2016, Journal of Clinical Microbiology.

Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.

D. Gerding, Stuart Johnson, C. Kelly, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multilocus Variable-Number Tandem-Repeat Analysis for Investigation of Clostridium difficile Transmission in Hospitals

Jane W. Marsh, Carlene A. Muto, D. Gerding, 2006, Journal of Clinical Microbiology.

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis

D. Gerding, M. Olsen, E. Dubberke, 2016, PloS one.

Fourteen-Genome Comparison Identifies DNA Markers for Severe-Disease-Associated Strains of Clostridium difficile

E. Mardis, Mark A. Miller, K. Dewar, 2011, Journal of Clinical Microbiology.

Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA

C. Donskey, D. Gerding, A. Sethi, 2010, Emerging infectious diseases.

Effectiveness of Alcohol-Based Hand Rubs for Removal of Clostridium difficile Spores from Hands

Stuart Johnson, Jorge P. Parada, D. Gerding, 2010, Infection Control & Hospital Epidemiology.

Multilocus Variable-Number Tandem-Repeat Analysis and Multilocus Sequence Typing Reveal Genetic Relationships among Clostridium difficile Isolates Genotyped by Restriction Endonuclease Analysis

Jane W. Marsh, D. Gerding, L. Harrison, 2009, Journal of Clinical Microbiology.

Present and Future Management Options for Clostridium difficile Infection

D. Gerding, 2009 .

Measuring the severity of Clostridium difficile infection: implications for management and drug development

D. Gerding, Stuart Johnson, G. Tillotson, 2008, Expert review of anti-infective therapy.

Changing Epidemiology of Clostridium difficile-Associated Disease: Experience and Perception of Infectious Diseases Consultants

D. Gerding, L. McDonald, L. Strausbaugh, 2006 .

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

M. Samore, D. Gerding, F. Tenover, 1999, The New England journal of medicine.

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems

L. Peterson, D. Gerding, S. Johnson, 1993, Journal of clinical microbiology.

Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106.

D. Gerding, D. Hecht, L. Kociolek, 2018, Microbes and infection.

Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain

C. Donskey, D. Gerding, S. Sambol, 2020, Emerging infectious diseases.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

D. Gerding, Wayne N. Campbell, J. Zenilman, 2017, The Lancet. Infectious diseases.

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis

Mark A. Miller, E. Kuijper, D. Gerding, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital.

Stuart Johnson, D. Gerding, M. Rupnik, 2004, Journal of medical microbiology.

Clinical recognition and diagnosis of Clostridium difficile infection.

J. Bartlett, D. Gerding, Dale N Gerding, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

Roger Baxter, Israel Lowy, D. Gerding, 2010, Vaccine.

Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

T. Louie, D. Gerding, S. Chasan-Taber, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COMPARISON OF THE VIDAS C. DIFFICILE TOXIN A WITH C.DIFFICILE CULTURE AND CYTOTOXIN AND LATEX TESTS

L. Peterson, D. Gerding, M. Olson, 1992 .

Acquisition of Clostridium difficile and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Tube Feeding

D. Gerding, K. Savik, Stuart Johnson, 1998, Annals of Internal Medicine.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Roger Baxter, Israel Lowy, D. Gerding, 2010, The New England journal of medicine.

Toxinotype V Clostridium difficile in Humans and Food Animals

D. Gerding, B. Limbago, L. McDonald, 2008, Emerging infectious diseases.

Impact of Strain Type on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay Approaches

Ellen Jo Baron, Christopher W. Woods, Elizabeth M. Marlowe, 2010, Journal of Clinical Microbiology.

Ten Years of Prospective Clostridium difficile-Associated Disease Surveillance and Treatment at the Minneapolis VA Medical Center, 1982–1991

D. Gerding, James T. Lee, M. Olson, 1994, Infection Control & Hospital Epidemiology.

Bacterial agglutination and polyacrylamide gel electrophoresis for typing Clostridium difficile.

W. C. Cheng, L. Peterson, D. Gerding, 1986, The Journal of infectious diseases.

Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issue.

D. Gerding, S. Faust, M. Wilcox, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure

L. Peterson, D. Gerding, C. Clabots, 1989, Journal of clinical microbiology.

Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests

L. Peterson, D. Gerding, M. Olson, 1992, Journal of clinical microbiology.

Evaluation of cycloserine-cefoxitin-fructose agar and cycloserine-cefoxitin-fructose broth for recovery of Clostridium difficile from environmental sites

L. Peterson, D. Gerding, C. Clabots, 1991, Journal of clinical microbiology.

Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates

D. Gerding, P. Gumerlock, Stuart Johnson, 1995, Journal of clinical microbiology.

Wide diversity of Clostridium difficile types at a tertiary referral hospital.

M. Samore, D. Gerding, A. Karchmer, 1994, The Journal of infectious diseases.

Treatment of Clostridium difficile-associated diarrhea and colitis.

D. Gerding, 2000, Current topics in microbiology and immunology.

Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea.

L. Peterson, D. Gerding, M. Olson, 1988, Diagnostic microbiology and infectious disease.

C ENTER , 1982-1991

D. Gerding, James T. Lee, M. Olson, 2014 .

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

D. Gerding, E. Dubberke, G. Rahav, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes

J. Meek, D. Gerding, Z. Beldavs, 2016, Open forum infectious diseases.

Chapter 14 – Pathology and Diagnosis of Clostridium difficile Disease

L. Peterson, D. Gerding, 1988 .

Natural Clostridioides difficile toxin immunization in colonized infants.

R. Tanz, D. Gerding, T. Savidge, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Results from Two Multinational, Randomized, Controlled Trials

T. Louie, D. Gerding, Stuart Johnson, 2014 .

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection with Greater Severity and Higher Recurrence Rates.

D. Gerding, G. Dumyati, M. Kainer, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates”

S. Berenholtz, D. Classen, D. Anderson, 2014, Infection Control & Hospital Epidemiology.

The epidemiology of Clostridium difficile infection inside and outside health care institutions.

D. Gerding, F. Lessa, 2015, Infectious disease clinics of North America.

245 – Clostridium difficile Infection

D. Gerding, V. Young, 2015 .

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

C. Donskey, D. Gerding, D. Yokoe, 2014, Infection Control & Hospital Epidemiology.

Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.

L. Peterson, D. Gerding, Stuart Johnson, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of C. difficile toxin A (enterotoxin)

L. Peterson, D. Gerding, C. Shanholtzer, 1987, American journal of clinical pathology.

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin

D. Gerding, E. Goldstein, S. Sambol, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intravenous metronidazole and Clostridium difficile-associated diarrhea or colitis.

L. Peterson, D. Gerding, S. Johnson, 1989, The Journal of infectious diseases.

asso-Detection of Clostridium difficile Toxins A (enterotoxin) and B (cytotoxin) in Clinical Specimens Evaluation of a Latex Agglutination Test

L. Peterson, D. Gerding, C. Shanholtzer, 2016 .

Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.

D. Gerding, S. Sambol, Stuart Johnson, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

D. Gerding, Stuart Johnson, L. Danziger, 2014, Open forum infectious diseases.

Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.

D. Gerding, Stuart Johnson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.

D. Gerding, R. Carman, M. C. McEllistrem, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Onset of Symptoms and Time to Diagnosis of Clostridium difficile–Associated Disease Following Discharge From an Acute Care Hospital

D. Gerding, C. Evans, Stuart Johnson, 2007, Infection Control & Hospital Epidemiology.

Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System

M. Samore, D. Gerding, K. Dukes, 2018, Infection Control & Hospital Epidemiology.

Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse

D. Gerding, A. Driks, V. Poroyko, 2015, Infection and Immunity.

Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study.

D. Gerding, S. Shulman, Sameer J. Patel, 2015, The Journal of pediatrics.

Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital

D. Gerding, T. Larson, C. R. Garrett, 1986, Antimicrobial Agents and Chemotherapy.

Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update

David J Weber, C. Donskey, D. Gerding, 2023, Infection Control & Hospital Epidemiology.

Influenza B: hospital activity during a community epidemic.

B. Bean, L. Peterson, D. Gerding, 1983, Diagnostic microbiology and infectious disease.

Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals

Helen Burstin, Sanjay Saint, Victoria Fraser, 2008, Infection Control & Hospital Epidemiology.

Acceptance of Hepatitis B Vaccine by Hospital Personnel

D. Gerding, R. Petzel, K. Crossley, 1985, Infection Control.

Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates”

S. Berenholtz, D. Classen, D. Anderson, 2014, Infection Control & Hospital Epidemiology.

Evaluation of new blood culture processing systems

L. Peterson, D. Gerding, C. Fasching, 1984, Journal of clinical microbiology.

Staphylococcus aureus bacteriuria.

D. Gerding, K. Crossley, P. Démuth, 1979, Archives of internal medicine.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.

S. Berenholtz, D. Classen, R. Weinstein, 2014, American journal of infection control.

Antimicrobial Cycling: Lessons Learned From the Aminoglycoside Experience

D. Gerding, 2000, Infection Control & Hospital Epidemiology.

Clostridium difficile Infection Among Children Across Diverse US Geographic Locations

J. Meek, D. Gerding, Z. Beldavs, 2014, Pediatrics.

DNA Fingerprinting byPulsed Field GelElectrophoresis and Ribotyping ToDistinguish Pseudomonas cepacia Isolates froma Nosocomial Outbreak

D. Gerding, M. Vasil, Edward N. JANOFFl, 1991 .

Management of Clostridium difficile infection: thinking inside and outside the box.

D. Gerding, Stuart Johnson, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Healthcare facility-onset, healthcare facility-associated Clostridioides difficile infection in Veterans with spinal cord injury and disorder

D. Gerding, S. Burns, C. Evans, 2019, The journal of spinal cord medicine.

Treatment of Staphylococcal Infections-Reply

L. Peterson, D. Gerding, 1980 .

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.

T. Louie, D. Gerding, M. Wilcox, 2019, The Lancet. Infectious diseases.

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection

T. Louie, D. Gerding, E. Dubberke, 2016, Open forum infectious diseases.

A Tapered-Pulsed Fidaxomicin Regimen following Treatment in Patients with Multiple Clostridioides difficile Infection Recurrences.

D. Gerding, Stuart Johnson, L. Danziger, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses

L. Peterson, D. Gerding, W. H. Hall, 1980, Antimicrobial Agents and Chemotherapy.

Trends in incidence of long‐term‐care facility onset Clostridium difficile infections in 10 US geographic locations during 2011‐2015

D. Gerding, W. Bamberg, Z. Beldavs, 2018, American journal of infection control.

Effectiveness of Hand Hygiene for Removal of Clostridium difficile Spores from Hands

D. Gerding, S. Sambol, Stuart Johnson, 2013, Infection Control & Hospital Epidemiology.

Current and future trends in clostridioides (clostridium) difficile infection management.

D. Gerding, S. Khanna, 2019, Anaerobe.

Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)

D. Gerding, G. Rahav, M. Wilcox, 2015 .

Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection.

D. Gerding, Stuart Johnson, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spore Formation and Toxin Production in Clostridium difficile Biofilms

D. Gerding, A. Driks, J. Foley, 2014, PloS one.

Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection

D. Gerding, Stuart Johnson, Melinda M. Soriano, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.

D. Reda, R. Ringer, C. Donskey, 2022, Contemporary Clinical Trials.

Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.

D. Gerding, E. Goldstein, M. Wilcox, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is pulsed dosing the answer to treatment of Clostridium difficile infection?

D. Gerding, 2017, Lancet. Infectious Diseases (Print).

Redefining Clostridioides difficile infection antibiotic response and clinical outcomes.

K. Garey, E. Kuijper, C. Kelly, 2023, The Lancet. Infectious diseases.

Sustained Clinical Response as an Endpoint in Treatment Trials of Clostridium difficile-Associated Diarrhea

T. Louie, D. Gerding, S. Gorbach, 2012, Antimicrobial Agents and Chemotherapy.

Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis

D. Gerding, S. Shulman, Sameer J. Patel, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents

C. Donskey, M. Samore, D. Gerding, 2018, Infection control and hospital epidemiology.

Effects of method of antibiotic administration on extravascular penetration: cross-over study of cefazolin given by intermittent injection or constant infusion.

L. Peterson, D. Gerding, C. Fasching, 1981, The Journal of antimicrobial chemotherapy.

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile

D. Gerding, D. Hecht, D. Olsen, 2014, Antimicrobial Agents and Chemotherapy.

Serratia Species During Increased UseofAmikacin intheHospital

D. Gerding, T. Larson, 1986 .

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014

D. Snydman, B. A. Forbes, Robin Patel, 2017, Open Forum Infectious Diseases.

To treat or not to treat: Clostridioides difficile infection (CDI) guidelines, diagnostic algorithms, and CDI reporting.

D. Gerding, 2023, Infection control and hospital epidemiology.

1665. Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test

D. Gerding, S. Fridkin, L. Winston, 2022, Open Forum Infectious Diseases.

Influence ofProtein Binding on Therapeutic Efficacy ofCefoperazone

L. Peterson, D. Gerding, C. Fasching, 1989 .

Reply to Million et al.

D. Gerding, E. Dubberke, Ken Blount, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection.

Judong Shen, R. Railkar, D. Gerding, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IFFICILE FROM B ARE H ANDS AND G LOVED H ANDS

D. Gerding, C. Clabots, K. Bettin, 2014 .

Gentamicin Intravenous Infusion Rate: Effect on Interstitial Fluid Concentration

L. Peterson, D. Gerding, W. H. Hall, 1977, Antimicrobial Agents and Chemotherapy.

Effect ofMethodofAdministration onExtravascular Penetration ofFourAntibiotics

D. Gerding, T. E. Russ, L. Etta, 1982 .

Microbiome Profile is Distinct in Patients with Successful Response to Microbiota-Based Drug RBX2660 Relative to Placebo Responders

D. Gerding, E. Dubberke, S. Khanna, 2017 .

Community-Associated Clostridium difficile Infection among Veterans with Spinal Cord Injury and Disorder

D. Gerding, S. Burns, C. Evans, 2014, Infection Control & Hospital Epidemiology.

624 – Comparison of Two Open-Label Trials Demonstrates Similar 6-Month Outcomes for Rbx2660 and Rbx7455—Investigational Microbiota Restoration Therapeutics Administered by Enema Or Oral Capsules for Preventing Recurrent Clostridium Difficile Infections

E. Deych, D. Gerding, E. Dubberke, 2019, Gastroenterology.

Burden of Clostridium difficile infection in the United States.

J. Meek, D. Gerding, S. Fridkin, 2015, The New England journal of medicine.

Prediction of peak penicillin and cephalosporin concentrations in canine serum as derived from in vitro serum and tissue quantitative protein binding.

L. Peterson, D. Gerding, W. H. Hall, 1979, Journal of Antimicrobial Chemotherapy.

D. Gerding, L. McDonald, M. Wilcox, 2010, Infection Control & Hospital Epidemiology.

Effect of the COVID-19 Pandemic on Rates and Epidemiology of Clostridioides difficile Infection in One VA Hospital

D. Gerding, Stuart Johnson, D. Leehey, 2023, Antibiotics.

K. Carroll, K. Garey, J. Bakken, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection Control and Hospital Epidemiology Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals Shea Position Paper Infection Co

D. Gerding, J. Mcgowan, F. Tenover, 2022 .

Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates”

S. Berenholtz, D. Classen, D. Anderson, 2014, Infection Control & Hospital Epidemiology.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults : 2010 Update by the Society for Healthcare Epidemiology of America ( SHEA ) and the Infectious Diseases Society of America

D. Gerding, L. McDonald, M. Wilcox, 2010 .

K. Carroll, K. Garey, J. Bakken, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

D. Gerding, J. Mcgowan, F. Tenover, 1997, Infection Control & Hospital Epidemiology.

Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?

D. Gerding, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Collins and Riley.

D. Gerding, L. McDonald, Stuart Johnson, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Fabre et al.

K. Garey, J. Bakken, D. Gerding, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

D. Snydman, D. Gerding, D. Hecht, 2016, Antimicrobial Agents and Chemotherapy.

Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment

D. Gerding, D. Drekonja, Jane H. Zhang, 2021, Clinical trials.

Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin

D. Gerding, S. Sambol, Stuart Johnson, 2023, Microbiology spectrum.

Immunoblots andPlasmid Fingerprints ComparedwithSerotyping andPolyacrylamide GelElectrophoresis forTyping Clostridium difficile

L. Peterson, D. Gerding, M. Mulligan, 1988 .

Strategies to prevent Clostridium diffic ile infections in acute care hospitals

D. Gerding, E. Dubberke, David C Classen, 2008 .

K. Garey, J. Bakken, D. Gerding, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027

D. Gerding, L. Kociolek, 2015, Journal of Clinical Microbiology.

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.

D. Gerding, Stuart Johnson, D. Hecht, 2009, Anaerobe.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

D. Gerding, Z. Beldavs, G. Dumyati, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Strategies to prevent Clostridium diffic ile infections in acute care hospitals

D. Gerding, E. Dubberke, David C Classen, 2008 .

Burden of Clostridium difficile infection in the United States.

J. Meek, D. Gerding, S. Fridkin, 2015, The New England journal of medicine.

Comparison of Strain Typing Results for Clostridium difficile Isolates from North America

A. Wortman, D. Gerding, T. Åkerlund, 2011, Journal of Clinical Microbiology.

Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates.

D. Gerding, Stuart Johnson, Anilrudh A. Venugopal, 2011, American journal of infection control.

Treatment of Clostridium difficile-associated diarrhea and colitis.

D. Gerding, 2000, Current Topics in Microbiology and Immunology.

ICE volume 35 issue 8 Cover and Front matter

Katherine, Hazen, Aiello, 2014, Infection Control & Hospital Epidemiology.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

T. V. Van Schooneveld, D. Gerding, D. Pardi, 2015, JAMA.

Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals

S. Saint, D. Classen, R. Weinstein, 2008, Infection Control & Hospital Epidemiology.

Beta-hemolytic streptococcal bacteremia in adults: association with cold weather in Minnesota.

D. Gerding, D. Trence, M. Khan, 1981, Minnesota medicine.

Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.

L. Peterson, D. Gerding, M. Schwartz, 1986, Archives of internal medicine.